Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Receives $19.25 Consensus PT from Analysts

Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Get Free Report) has earned an average rating of "Moderate Buy" from the nine analysts that are currently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $19.25.

Several analysts have commented on SBRA shares. Scotiabank lifted their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "sector perform" rating in a report on Friday, October 11th. Citizens Jmp raised shares of Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a research report on Tuesday. Mizuho reiterated a "neutral" rating and issued a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Citigroup raised Sabra Health Care REIT from a "neutral" rating to a "buy" rating and increased their target price for the stock from $17.00 to $20.00 in a research report on Friday, September 13th. Finally, JMP Securities upgraded Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 target price on the stock in a report on Tuesday.

Institutional Trading of Sabra Health Care REIT

Several large investors have recently bought and sold shares of the company. JPMorgan Chase & Co. boosted its stake in shares of Sabra Health Care REIT by 222.4% in the third quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust's stock valued at $183,996,000 after purchasing an additional 6,819,919 shares during the period. Wellington Management Group LLP boosted its position in Sabra Health Care REIT by 736.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,396,835 shares of the real estate investment trust's stock valued at $44,605,000 after buying an additional 2,110,307 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Sabra Health Care REIT by 324.3% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,404,576 shares of the real estate investment trust's stock valued at $26,139,000 after acquiring an additional 1,073,530 shares in the last quarter. Point72 Asset Management L.P. increased its position in shares of Sabra Health Care REIT by 152.7% during the second quarter. Point72 Asset Management L.P. now owns 1,732,274 shares of the real estate investment trust's stock worth $26,677,000 after acquiring an additional 1,046,748 shares during the last quarter. Finally, Thrivent Financial for Lutherans increased its position in shares of Sabra Health Care REIT by 1,557.9% during the third quarter. Thrivent Financial for Lutherans now owns 927,309 shares of the real estate investment trust's stock worth $17,258,000 after acquiring an additional 871,375 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Sabra Health Care REIT Trading Up 2.3 %

Shares of NASDAQ SBRA traded up $0.38 during midday trading on Wednesday, reaching $17.18. 2,442,943 shares of the stock were exchanged, compared to its average volume of 1,765,283. The stock has a 50 day moving average price of $18.05 and a 200-day moving average price of $17.44. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. The company has a market capitalization of $4.06 billion, a P/E ratio of 41.90, a P/E/G ratio of 2.20 and a beta of 1.26. Sabra Health Care REIT has a 52-week low of $12.83 and a 52-week high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. The firm had revenue of $178.00 million during the quarter, compared to analysts' expectations of $177.19 million. During the same period in the previous year, the firm posted $0.34 earnings per share. Equities research analysts expect that Sabra Health Care REIT will post 1.39 earnings per share for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.98%. The ex-dividend date was Friday, November 15th. Sabra Health Care REIT's dividend payout ratio is presently 292.68%.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.